v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income (loss) $ 709 $ (21,097)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 13,756 22,564
Non-cash operating lease costs 10,231 9,687
Stock-based compensation 18,584 20,581
Amortization of discount and debt issue costs 251 424
Gain on remeasurement of contingent consideration 0 (2,015)
Other, net 357 (47)
Change in operating assets and liabilities, net of businesses acquired:    
Patient accounts receivable, net (8,568) (50,532)
Prepaid expenses and other current assets (4,515) 2,491
Accounts payable (77) 4,981
Accrued payroll expenses (17,540) (2,045)
Operating lease liabilities (11,894) (9,608)
Other accrued expenses (4,386) 2,778
Net cash used in operating activities (3,092) (21,838)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchases of property and equipment (7,168) (5,104)
Net cash used in investing activities (7,168) (5,104)
CASH FLOWS FROM FINANCING ACTIVITIES    
Payments of long-term debt (1,813) (731)
Payments of contingent consideration 0 (1,700)
Taxes related to net share settlement of equity awards (8,162) 0
Net cash used in financing activities (9,975) (2,431)
NET DECREASE IN CASH AND CASH EQUIVALENTS (20,235) (29,373)
Cash and Cash Equivalents - Beginning of period 154,571 78,824
CASH AND CASH EQUIVALENTS – END OF PERIOD 134,336 49,451
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid for interest, net 4,382 6,270
Cash paid for taxes, net of refunds 609 (252)
SUPPLEMENTAL DISCLOSURES OF NON CASH INVESTING AND FINANCING ACTIVITIES    
Acquisition of property and equipment included in liabilities $ 2,348 $ 3,104